Tango Therapeutics shareholders elect Calhoun and Huber as Class I directors, ratify PwC as auditor

Tango Therapeutics, Inc.

Lesley Ann Calhoun elected with 74,549,730 votes for, 2,532,608 withheld, 4,658,458 broker non-votes.
Reid Huber elected with 74,547,606 votes for, 2,534,732 withheld, 4,658,458 broker non-votes.
PricewaterhouseCoopers ratified as independent auditor for FY2022 with 81,737,938 votes for, 400 against, 2,458 abstain.
Annual meeting held June 8, 2022; 81,740,796 shares represented (93.19% of outstanding).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.